DKK1 seems to have immunomodulatory effects in the tumor microenvironment, inducing immunosuppression and a low anti-tumor response by impeding a Natural Killer (NK) cell-mediated response and enhancing myeloid-derived suppressor cell activity [87]. This evidence concerns the gene DKK1 and neoplasm.